Skip to content

Ionis Pharmaceuticals IONS Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions

Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions at other companies

SBA Communications logo
SBA CommunicationsSBAC
$89.75K+124%
Essential Utilities logo
Essential UtilitiesWTRG
-$78.75K-202%
Baxter International logo
Baxter InternationalBAX
$64.5M+5,060%
SBA Communications logo
SBA CommunicationsSBAC
$89.75K+124%
RBC Bearings logo
RBC BearingsRBC
-$175K-147%
Essential Utilities logo
Essential UtilitiesWTRG
-$78.75K-202%

Other financials

Income statement

See full
Revenue$246.1M+87.0%
Gross profit$243.1M+86.8%
Operating income-$117.4M+20.0%
Net income-$92.5M+37.0%
EPS (diluted)-$0.56+39.8%

Balance sheet

See full
Cash & equivalents$173.4M-34.4%
Total debt$691.7M+334%
Total equity$491.4M+3.3%
Total assets$3.4B+22.6%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$21.8M+73.0%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$12.25B+159%
Enterprise value$12.77B+175%
P/S11.6×+5.0×

Profitability

See full
Gross margin98.4%-0.2pp
Operating margin-33.3%-11.0pp
Net margin-30.9%-10.5pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-67.6%-20.3pp
Debt / equity1.4×+1.1×
Current ratio4.1×-5.6×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions.

The official record: Ionis Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ionis Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ionis Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions?
Ionis Pharmaceuticals (IONS) reported unrecognized tax benefits, decrease resulting from prior period tax positions of $0 in Q4 2025.
How has Ionis Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions changed year-over-year?
Ionis Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions decreased by 100.0% year-over-year, from $27.5K to $0.
What is the long-term trend for Ionis Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions?
Over 2 years (2023 to 2025), Ionis Pharmaceuticals's unrecognized tax benefits, decrease resulting from prior period tax positions has grown at a -100.0% compound annual growth rate (CAGR), from $737K to $0.
What does unrecognized tax benefits, decrease resulting from prior period tax positions mean?
The reduction in tax reserves due to the settlement or resolution of tax issues from previous years.
How do you interpret unrecognized tax benefits, decrease resulting from prior period tax positions?
A decrease indicates that tax uncertainties are being resolved, which can lead to a more predictable tax profile.
How does unrecognized tax benefits, decrease resulting from prior period tax positions compare across companies?
Standard disclosure for companies managing complex global tax structures and audit risks.